Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Differentiation-inducing 5-FU prodrug developed at Spanish university

April 26, 1999

DuPont presents somatostatin analogues YH-137 and YH-138 with antiangiogenic effects

April 23, 1999

Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo

April 23, 1999

Extensive preclinical evaluation establishes potential of novel antitumor agent --CHS-828

April 22, 1999

Promising phase I/II data for 81C6 pave the way for phase III trials in brain tumor patients

April 22, 1999

Favorable efficacy and safety profile of CEP-701 in PDAC

April 22, 1999

PNU-159548 undergoes phase I trials; preclinical results presented at AACR meeting

April 22, 1999

Efficacy of IL-2 Gene Medicine is enhanced by combination with chemotherapeutic agent

April 22, 1999

GnRH pharmaccine reduces testosterone to castration levels

April 22, 1999

Small peptide from Angstrom highly active against human breast tumor xenografts

April 21, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...